Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

Core Viewpoint - The proposed sale of Penumbra, Inc. to Boston Scientific Corporation is under investigation to assess whether the offered consideration adequately reflects the company's value [1]. Group 1: Transaction Details - Shareholders of Penumbra will receive either $374.00 in cash or 3.8721 shares of Boston Scientific common stock for each share of Penumbra they own, subject to proration [1]. Group 2: Legal Investigation - Kahn Swick & Foti, LLC is investigating the adequacy of the proposed transaction and the process that led to it, focusing on whether the consideration undervalues Penumbra [1].